...
首页> 外文期刊>Molecular pharmaceutics >Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.
【24h】

Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.

机译:用于治疗生殖器感染的可注射PAMAM树状聚合物PEG水凝胶:制剂以及体外和体内评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Local intravaginal drug therapy is preferred for treatment of ascending genital infections during pregnancy. In the present study, an in situ forming biodegradable hydrogel for sustained release of amoxicillin in the cervicovaginal region is described. A generation 4 poly(amidoamine) [G4-(NH(2))(64)] dendrimer with peripheral thiopyridyl terminations is cross-linked with 8-arm polyethylene glycol (PEG) bearing thiol terminations. The hydrogels were formulated and tested in vivo in a pregnant guinea pig model for volume, retention times, biodegradation, tolerability and transport across fetal membrane. The physicochemical characterization of the hydrogels was carried out using differential calorimetry, SEM, and confocal imaging. The hydrogels offer antibacterial activity arising from sustained release of amoxicillin from gels. The in vivo studies in guinea pig showed that 100-200 muL of gel sufficiently covered the cervicovaginal region with a residence time of at least 72 h and gel was primarily retained in the maternal tissues without crossing the fetal membranes into the fetus. The dendrimer gels were stable up to 72 h, and the in vivo biodegradation of gel occurred after 72 h; this correlated well with the in vitro degradation pattern. The pH of the vagina was not altered upon application of the gel, and none of the animals aborted up to 72 h after application of gel. The histological evaluation of the cervical tissues showed absence of edema in the epithelial cell layer, no sloughing of the epithelial or superficial mucous layer, and absence of necrosis and infiltration of inflammatory cells in the submucosal layers, confirming that tissues were tolerant to the gel. The immunohistofluorescence images showed the localization of the gel components on the superficial mucified epithelial layer. The cross-linking density and swelling of hydrogels was impacted by the polymer content, and the 10% hydrogels exhibited the highest cross-link density. The in vitro drug release studies carried out using Franz diffusion cells showed that amoxicillin release from 6 and 10% gels was sustained for 240 h as compared to 3% gels. As the polymer concentration increased to 10%, the release pattern from gels approached diffusion controlled mechanism with diffusional exponent n = 0.49. In conclusion, the biodegradable in situ forming hydrogels of the present study offer a therapeutic option to provide sustained localized delivery of amoxicillin intracervically to the pregnant woman for the treatment of ascending genital infections.
机译:首选局部阴道内药物疗法来治疗怀孕期间上升的生殖器感染。在本研究中,描述了原位形成的可生物降解水凝胶,用于在宫颈阴道区域持续释放阿莫西林。具有外围硫代吡啶基末端的第4代聚(酰胺基胺)[G4-(NH(2))(64)]树状聚合物与带有硫醇末端的8臂聚乙二醇(PEG)交联。配制水凝胶并在怀孕的豚鼠模型中进行体内测试,以测定其体积,保留时间,生物降解,耐受性和跨胎膜运输。使用差示量热法,SEM和共聚焦成像进行水凝胶的物理化学表征。水凝胶提供了阿莫西林从凝胶中持续释放所产生的抗菌活性。在豚鼠中进行的体内研究表明,100-200μL的凝胶足以覆盖宫颈阴道区域,停留时间至少为72 h,并且凝胶主要保留在母体组织中,而不会穿过胎膜进入胎儿。树枝状聚合物凝胶在长达72 h内保持稳定,而凝胶的体内生物降解发生在72 h之后。这与体外降解模式密切相关。施用凝胶后阴道的pH值没有改变,并且在施用凝胶后72小时内没有动物流产。宫颈组织的组织学评估显示上皮细胞层无水肿,上皮或浅层粘液层无脱落,粘膜下层无坏死和炎性细胞浸润,证实组织对凝胶耐受。免疫组织荧光图像显示凝胶成分在浅化的粘液上皮层上的定位。水凝胶的交联密度和溶胀受聚合物含量的影响,而10%的水凝胶表现出最高的交联密度。使用Franz扩散池进行的体外药物释放研究表明,与3%的凝胶相比,阿莫西林从6%和10%的凝胶中释放持续240小时。当聚合物浓度增加到10%时,凝胶的释放模式接近扩散控制机制,扩散指数n = 0.49。总之,本研究的可生物降解的原位形成水凝胶提供了一种治疗选择,可将阿莫西林持续向内向孕妇局部递送,以治疗上升的生殖器感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号